Using Design Controls to Reduce Time to Market

Design control requirements ensure good engineering practices, and thus increased efficiency and shorter development cycles.

David Vogel

January 1, 2007

11 Min Read
Using Design Controls to Reduce Time to Market


FDA's quality system regulation (QSR) is often perceived by medical product developers as unnecessary overhead. Software developers, in particular, often see it as a nuisance that delays the completion of the development of the product. Actually, just the opposite may be true. Understanding and following the good engineering and project-management principles outlined in the QSR can help manufacturers shorten the development cycle. Not only is the time to market faster, but the end result should also be a more stable, more reliable, and higher-quality product. The difference in both timeliness and quality can be enormous.

Subpart C of the QSR focuses on design controls. For software, the design control requirements are further interpreted in FDA's “General Principles of Software Validation,” often referred to as the GPSV.

An obvious question is, “How can following regulations help me get products out to the market faster?” The answer is simply that design control requirements add no more overhead than would be required by a good engineering process. A well-defined engineering process facilitates communication between stakeholders and development team members and leaves a documentation trail for those who will maintain the product in the future.

Design controls require that medical devices be developed using a formal, documented engineering process of the device manufacturer's choosing. Following a defined engineering process is far more efficient than defaulting to uncoordinated development.


The Value of Design Controls: A Concrete Example

The QSR requires developers to plan before they act. A nonsoftware engineer once equated the discipline of software development to that of pouring concrete. One would never mix and pour concrete before developing a plan and building forms that would define the shape of the concrete. Both the plan and the forms are needed to guide and control the concrete so that when it hardens, it conforms to the desired shape. Without forms or molds, it would be difficult to shape and reshape poured concrete so that it would ultimately harden as desired. Once concrete has hardened, it is impossible to reshape it. (See the sidebar, “The Value of Design Controls: A Concrete Example.”)

The same concepts apply to software. Software without a detailed set of requirements or specifications is like wet concrete without forms. It must be shaped and reshaped, designed and redesigned, until it hardens. If the end result doesn't meet the customer's needs, software, like concrete, becomes difficult to change late in the project. Patched software is much like patched concrete. It seldom looks as good as the original, and the structure is usually less sound.

Design controls for pouring concrete would require the following steps:

  • Identify the user's needs.

  • Develop a plan for achieving the desired result.

  • Build and verify the forms before the concrete is poured.

None of these steps would be considered nonessential overhead for pouring concrete. Everyone would agree that following this process would get the project done rapidly, with a high-quality result. Unfortunately, the same cannot always be said for software development.

FDA established the design control requirements for good reasons. As the agency notes:

Since early 1984, FDA has identified lack of design controls as one of the major causes of device recalls. The intrinsic quality of devices, including their safety and effectiveness, is established during the design phase.

This is especially true for medical device software, where, except for controlling what version of software is installed, the only control of quality takes place prior to the release of the software.

The design control requirements in the QSR are straightforward. They require the developer to prepare a plan, analyze patient and user risks, identify requirements, develop a design to realize the requirements, and implement the design. These steps must be done in a controlled way with appropriate reviews, approvals, validation, and management of the configuration and versioning of the software. In other words, the development process needs appropriate cross-checks. This approach provides a logical framework, yet is not too demanding in the details. The regulation allows a medical device manufacturer to achieve these objectives through any corporate process, following any life-cycle model.

Why Device Manufacturers Should Want Design Controls

The design control requirements read like a good textbook on engineering project management. There are plenty of reasons medical device manufacturers should want to implement design controls regardless of the regulations.

Controlling the Source of Design

Inputs. When designing a new product, all stakeholder needs must be considered. That includes the needs of the users (patients, clinicians, and others), marketing (what's needed to be sure it sells), manufacturing, service, training, and legal factors, as well as any important design elements that must be implemented to ensure the safe and effective operation of the device. Of course, FDA is really only concerned with user needs as they relate to the safe and effective operation of the device, but it's clear that the advantages of a controlled design process reach far beyond the regulatory requirements.

A controlled design process identifies as many needs and requirements as possible early in the development life cycle and allows for additional requirements or needs to be discovered as the development process progresses. The reviews and approvals act as a cross-check that all stakeholder needs have been considered and captured, and that they are traceable to detailed design documents and verification tests ensuring that they have been implemented correctly.


Developing Embedded Software

Out-of-control design processes often allow programmers to start writing software on day one of the project. At such an early stage, there is no assurance that the programmer has addressed or is even aware of the needs of all the product stakeholders. There are no documented requirements to verify the device against to ensure that user needs have been addressed properly, if at all. (See the sidebar, “Developing Embedded Software.”)

The out-of-control design process usually follows an iterative cycle of implementation, followed by exercising and critiquing the software, followed by some less-than-enthusiastic reimplementation (patching) to address the criticisms of the prior iteration. The programmers may have implemented a beautifully engineered software design, but unless they perfectly identified and implemented the needs of all the product stakeholders, they may have beautifully engineered the wrong product.

Promoting Communication with the Project Team. Capturing design inputs is an example of using the design control requirements early in the process to improve the quality and efficiency of medical device development. A prime mechanism for improving the process is to promote the communication of the design inputs to the development team through documentation.

Improving communications throughout the product development (and validation) life cycle can only help make the process more efficient. Yet there is a perception in the industry that documentation adds to the development overhead. A number of factors account for this (false) impression.

The team isn't really following the process. In other words, if programmers start writing the software before the preliminary requirements and design documents are completed, they see no value in retrospectively documenting requirements and designs, and, in fact, they are right. The value (other than regulatory value) is in using the documentation to make the development process more efficient. If the software has evolved iteratively, there is little value in retroactively documenting the process. The residual value is to comply with regulations and to support maintenance of the product. Unfortunately, because the development team views this as an overhead task, they are not likely to give it the thorough treatment that would be necessary to fulfill even these needs.

Times have changed. Perhaps there was a time 30 years ago that a single programmer could produce reasonable software and maintain it without a formal process. However, 30 years ago, embedded software fit into 16-Kb EPROMs. A single programmer could manage this in his head without documentation simply because the applications were so limited, and a development team often was composed of a single software guru.

Those days are behind us. Modern medical device software often is many thousands or even millions of lines long. Development teams typically include more than one person. In fact, development teams commonly comprise internal team resources and outsourced resources—both of which could be located anywhere in the world. Multi-time-zone development teams are quite common.

Software development evolved from a one-person task to two- and three-person teams that operated by sharing details over the cubicle wall. Now, with the size and complexity of modern medical software, the development process is uncoordinated and chaotic without formal, controlled documentation of the requirements and designs. Unfortunately, many software professionals have been in the industry long enough to remember the days when software could be developed by two-person teams. It is not unusual for these professionals to think the development and management techniques of 20–30 years ago should still apply today.

Thinking ahead isn't easy. Engineering products is not easy. Gathering, organizing, documenting, reviewing, negotiating, and revising requirements and designs is a difficult and imperfect activity that requires both technical and social skills. Early life-cycle phases require a lot of creativity and imagination to design novel ways to solve a problem and to anticipate what might go wrong. There are frequently differences of opinion among team members. These differences require negotiation and compromise.

Programmers can become quite expert in the complex web of computer languages, tools, operating systems, and off-the-shelf components that are used to create medical device software. Clearly, these skill sets are fundamental to a company's ability to develop and produce software-controlled medical devices. But it must be clearly understood that the skills that are required for programmers and software engineers are not the only skills needed for developing products.

Increasing the Efficiency of the Product Development Process. Increasing efficiency is the key to getting products out the door faster. Gathering requirements, communicating through written documentation, and verification of testing activities are three areas that are critical to increased efficiency.

Gathering requirements early cuts down on the number of implementation iterations. By starting the implementation process before the requirements and designs are complete, people get a false sense that the schedule is being advanced. There is no reason that independent sections of functionality that are well-defined and designed can't be implemented while other functionality stabilizes. Too often, however, development teams turn the programmers loose prematurely in hopes that they will figure out the right solution in coding language that the team couldn't agree to in English. It is much faster to turn around natural-language descriptions of product requirements than computer code.

Communicating through written documentation increases the efficiency of the development process. Detailed needs and requirements allow for detailed designs. Detailed designs allow for more parallelism in the implementation process because coordination of activities is partially accomplished through documentation.

Early verification testing activities add efficiency and may cut time from the development schedule. Defining requirements early in the development process allows the verification test team to begin development of test protocols in parallel with software development. Early testing of prototype software reveals problems that can be solved early in the implementation process. The parallel implementation and verification activities also result in less testing time at the end of the project when the software is nearly finished.

Do Design Controls Stifle Creativity?

The requirements in the QSR aren't very onerous. They are actually quite logical. Most texts on software engineering and the management of software development projects, though they may differ in the details, agree with the principles of the design control requirements.

A common objection to design control requirements is that they stifle the creativity of the programmers and software engineers. On the contrary, these requirements do not apply to the research phases of a product's life cycle, only to the development phases. It is important to remember, though, that the research phase does present some opportunities for rapid prototyping and experimenting with product ideas prior to the formal product development process, which would fall under the regulatory requirements.

Creativity should be emphasized early in the development process. Creativity related to what the product will do and how it will interact with users should be addressed in requirements documents that all interested parties have a chance to review and comment on. Creativity related to how the software and data will be structured to meet those requirements should be handled in the design phase and documented in design documents that can be reviewed by the other members of the product development team.

Creativity related to product design should be discouraged during the implementation process. Any creative changes during this phase will be largely hidden from the rest of the development team and from the requirements stakeholders. The implementation phase should be devoted to the implementation of the creative product and software designs of earlier phases. Any creativity in the implementation phase should be limited to creative ways to use the programming language to implement the documented designs. Even then, too much creativity can lead to software that is difficult to understand and maintain.


Although the design control requirements in the QSR are often perceived by medical product developers as unnecessary, this is simply untrue. It is especially important to implement design controls for the development of medical software. Good engineering and project management principles can actually shorten the product development cycle. Moreover, the final product will be more stable, more reliable, and higher quality.


The author thanks Eric Smith of Wiklund Research and Development for introducing him to the comparison of software to concrete.

David Vogel is president of Intertech Engineering Associates Inc. (Norwood, MA). He can be contacted at [email protected].

Copyright ©2007 Medical Device & Diagnostic Industry

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like